GLP-1 / Metabolic
Understanding GLP-1 Receptor Agonists in Research
Published 1 June 2025
GLP-1 receptor agonists are a class of peptides that mimic the action of native glucagon-like peptide-1. In research contexts, these compounds are studied for their effects on pancreatic beta-cell function, gastric motility, and various metabolic pathways.
Synthetic GLP-1 receptor agonists such as Semaglutide and Tirzepatide are frequently used in in-vitro research models studying insulin secretion, cellular signalling, and related metabolic mechanisms.
This article provides a neutral overview of the structural characteristics and studied mechanisms of this compound class for research reference only.